Bd and biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development

Franklin lakes, n.j. & san diego--(business wire)--bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, and biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with bd flow cytometry instruments to accelerate drug discovery and development. together, the companies intend to develop new software capabilities within.
BDX Ratings Summary
BDX Quant Ranking